Jeremy Welsch University of Michigan, Medical School
 3 protocols

Longping Tse University of North Carolina at Chapel Hill
 28 protocols

Masfique Mehedi University of North Dakota
 3 protocols

Ran Chen Zhejiang JFK Biological Technology Co. Ltd.
 6 protocols

Reviewer
George William Carnell
  • Post-Doc, University of Cambridge
Research focus
  • 2 Author merit

Education

PhD, University of Kent, 2018

Lab information

Heeney lab

2 Protocols published
A Lentiviral Pseudotype ELLA for the Measurement of Antibodies Against Influenza Neuraminidase
Authors:  Fabrizio Biuso, George Carnell, Emanuele Montomoli and Nigel Temperton, date: 07/20/2018, view: 5763, Q&A: 0
This protocol describes the rapid and safe production of lentiviral pseudotypes characterized by a lentiviral core containing a reporter, in conjunction with avian influenza haemagglutinin (HA) and human neuraminidase (NA) glycoproteins on the ...
More >
An Optimized Method for the Production Using PEI, Titration and Neutralization of SARS-CoV Spike Luciferase Pseudotypes
Authors:  George Carnell, Keith Grehan, Francesca Ferrara, Eleonora Molesti and Nigel Temperton, date: 08/20/2017, view: 13628, Q&A: 1
The protocol outlined represents a cost-effective, rapid and reliable method for the generation of high-titre viral pseudotype particles with the wild-type SARS-CoV spike protein on a lentiviral vector core using the widely available transfection ...
More >
5 Protocols reviewed
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike
Authors:  Leila Mekkaoui, Emma M. Bentley, Mathieu Ferrari, Katarina Lamb, Katarzyna Ward, Rajeev Karattil, Zulaikha Akbar, Reyisa Bughda, James Sillibourne, Shimobi Onuoha, Giada Mattiuzzo, Yasu Takeuchi and Martin Pule, date: 08/20/2021, view: 1941, Q&A: 0

The use of recombinant lentivirus pseudotyped with the coronavirus Spike protein of SARS-CoV-2 would circumvent the requirement of biosafety-level 3 (BSL-3) containment facilities for the handling of SARS-CoV-2 viruses. Herein, we describe a fast

...
More >
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike
Authors:  Leila Mekkaoui, Emma M. Bentley, Mathieu Ferrari, Katarina Lamb, Katarzyna Ward, Rajeev Karattil, Zulaikha Akbar, Reyisa Bughda, James Sillibourne, Shimobi Onuoha, Giada Mattiuzzo, Yasu Takeuchi and Martin Pule, date: 07/20/2021, view: 1021, Q&A: 0

The use of recombinant lentivirus pseudotyped with the coronavirus Spike protein of SARS-CoV-2 would circumvent the requirement of biosafety-level 3 (BSL-3) containment facilities for the handling of SARS-CoV-2 viruses. Herein, we describe a fast

...
More >
Other Resources
Bio-protocol Exchange
Bio-protocol Webinars
Bio-thing
For Advertisers
Advertising Policy
Advertising Integrity Board
For Authors
Submission Procedure
Preparation Guideline
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Copyright & Permissions
About
About Us
Aims & Scope
Advisors
Editors
Reviewers

News
Become a Reviewer
Become an Ambassador
©  Bio-protocol LLC. ISSN: 2331-8325 Terms of Service | Privacy Policy | Contact Us
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.